Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | GUSB | P08236 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | C1R | P00736 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.36 |
| ▸ | KLK3 | P07288 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15822883 | 0.84 | KDM4E (0.43) | KDM4EATML3MBTL1HPRT1MEN1 | |
| SCHEMBL31907 | 0.81 | ALDH1A1 (0.50) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL16932047 | 0.80 | ALDH1A1 (0.47) | KDM4EATML3MBTL1HPRT1MEN1 | |
| SCHEMBL15821904 | 0.79 | KDM4E (0.43) | KDM4EATML3MBTL1HPRT1MEN1 | |
| SCHEMBL17548824 | 0.78 | KDM4E (0.38) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL14756544 | 0.78 | ALDH1A1 (0.50) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL20595209 | 0.78 | KDM4E (0.46) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL17861293 | 0.78 | KDM4E (0.46) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL30562779 | 0.78 | KDM4E (0.46) | KDM4EATML3MBTL1MEN1KMT2A | |
| SCHEMBL16932050 | 0.78 | ALDH1A1 (0.47) | KDM4EATML3MBTL1HPRT1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | SFC CO., LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180072753-A1 | NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME | OR10J3, CRY1, NR2E3 | KDM4E 1697/4885ATM 2504/4885L3MBTL1 308/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.